SEC Comment Letter for APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636) — Apr 7, 2021
APPLIED GENETIC TECHNOLOGIES CORP (CIK 0001273636)
Date: April 7, 2021 · CIK: 0001273636 · Accession: 0000000000-21-004189
AI Filing Summary & Sentiment
File numbers found in text: 333-255008
Letter
United States securities and exchange commission logo April 7, 2021 Susan B. Washer President and Chief Executive Officer Applied Genetic Technologies Corporation 14193 NW 119th Terrace, Suite 10 Alachua, FL 32615 Re:Applied Genetic Technologies Corporation Registration Statement on Form S-3 Filed April 2, 2021 File No. 333-255008 Dear Ms. Washer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact David Gessert at 202-551-2326 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 7, 2021
Susan B. Washer
President and Chief Executive Officer
Applied Genetic Technologies Corporation
14193 NW 119th Terrace, Suite 10
Alachua, FL 32615
Re:Applied Genetic Technologies Corporation
Registration Statement on Form S-3
Filed April 2, 2021
File No. 333-255008
Dear Ms. Washer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact David Gessert at 202-551-2326 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences